These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29416345)

  • 1. The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma.
    Ren L; Yu Y
    Ther Clin Risk Manag; 2018; 14():179-187. PubMed ID: 29416345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of microRNAs in the Diagnosis and Treatment of Pancreatic Adenocarcinoma.
    Diab M; Muqbil I; Mohammad RM; Azmi AS; Philip PA
    J Clin Med; 2016 Jun; 5(6):. PubMed ID: 27322337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA and Gene Expression in Pancreatic Ductal Adenocarcinoma.
    Tesfaye AA; Azmi AS; Philip PA
    Am J Pathol; 2019 Jan; 189(1):58-70. PubMed ID: 30558723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
    Brunetti O; Russo A; Scarpa A; Santini D; Reni M; Bittoni A; Azzariti A; Aprile G; Delcuratolo S; Signorile M; Gnoni A; Palermo L; Lorusso V; Cascinu S; Silvestris N
    Oncotarget; 2015 Sep; 6(27):23323-41. PubMed ID: 26259238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection.
    Gablo N. A; Procházka V; Hlavsa J; Kiss I; Srovnal J; Kala Z; Slabý O
    Klin Onkol; 2019; 32(Suppl 1):174-176. PubMed ID: 31064193
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Yu SN; Ma YH; Zhao WG; Jin XL; Yang HY; Liu PP; Chen J
    Chronic Dis Transl Med; 2016 Dec; 2(4):215-222. PubMed ID: 29063045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection.
    Gablo N; Trachtova K; Prochazka V; Hlavsa J; Grolich T; Kiss I; Srovnal J; Rehulkova A; Lovecek M; Skalicky P; Berindan-Neagoe I; Kala Z; Slaby O
    J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32751582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of microRNA-based therapy for pancreatic cancer.
    Fesler A; Ju J
    J Pancreatol; 2019 Dec; 2(4):147-151. PubMed ID: 32133215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions.
    Hernandez YG; Lucas AL
    World J Gastrointest Oncol; 2016 Jan; 8(1):18-29. PubMed ID: 26798434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.
    Szafranska AE; Davison TS; John J; Cannon T; Sipos B; Maghnouj A; Labourier E; Hahn SA
    Oncogene; 2007 Jun; 26(30):4442-52. PubMed ID: 17237814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
    Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
    Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Circulating MicroRNAs in Patients with Early-Stage Pancreatic Adenocarcinoma.
    Eid M; Karousi P; Kunovský L; Tuček Š; Brančíková D; Kala Z; Slabý O; Mayer J; Kontos CK; Trna J
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNAs as Potential Diagnostic, Prognostic and Therapeutic Targets in Pancreatic Cancer.
    Ebrahimi S; Hosseini M; Ghasemi F; Shahidsales S; Maftouh M; Akbarzade H; Parizadeh SA; Hassanian SM; Avan A
    Curr Pharm Des; 2016; 22(42):6444-6450. PubMed ID: 27539232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
    Mardin WA; Mees ST
    Ann Surg Oncol; 2009 Nov; 16(11):3183-9. PubMed ID: 19636633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: a meta-analysis.
    Chhatriya B; Mukherjee M; Ray S; Sarkar P; Chatterjee S; Nath D; Das K; Goswami S
    BMC Cancer; 2019 Dec; 19(1):1175. PubMed ID: 31795960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA based prognostic biomarkers in pancreatic Cancer.
    Guo S; Fesler A; Wang H; Ju J
    Biomark Res; 2018; 6():18. PubMed ID: 29942514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential MicroRNA Expression Profiles as Potential Biomarkers for Pancreatic Ductal Adenocarcinoma.
    Zhu Y; Wang J; Wang F; Yan Z; Liu G; Ma Y; Zhu W; Li Y; Xie L; Bazhin AV; Guo X
    Biochemistry (Mosc); 2019 May; 84(5):575-582. PubMed ID: 31234772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical Implications.
    Sun T; Kong X; Du Y; Li Z
    Gastroenterol Res Pract; 2014; 2014():386561. PubMed ID: 24899890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of MicroRNAs in Resistance to Current Pancreatic Cancer Treatment: Translational Studies and Basic Protocols for Extraction and PCR Analysis.
    Garajová I; Le Large TY; Giovannetti E; Kazemier G; Biasco G; Peters GJ
    Methods Mol Biol; 2016; 1395():163-87. PubMed ID: 26910074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.